Skip to main content

DAVENPORT & Co LLC

Position in IONS — Ionis Pharmaceuticals Inc

CIK 887777 RICHMOND, VA

Position in IONS

as of Mar 31, 2026 · filed Apr 15, 2026
Position Value
$17,889,291
+$651,460 QoQ
Shares Held
238,238
+9.3% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 85.27564872102687.ToString("F0")% Shared 0.ToString("F0")% None 14.724351278973128.ToString("F0")%

Common Shares in IONS Over Time

Shares Held

Position Value (USD)

Derivatives in IONS

reported options exposure · as of Dec 31, 2021
CallValue
$213,010
CallShares
7,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DAVENPORT & Co LLC holds $119,148,472 across 17 Biotechnology names. IONS ranks #2 (15.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 IONS
Ionis Pharmaceuticals Inc
This page
238,238 $17,889,291

All Filings in IONS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $17,889,291 238,238
2025-12-31 $17,237,831 217,897
2025-09-30 $4,092,871 62,563
2025-06-30 $2,561,946 64,843
2025-03-31 $1,701,376 56,393
2024-12-31 $2,193,390 62,740
2024-09-30 $3,028,455 75,598
2024-06-30 $3,845,113 80,678
2024-03-31 $3,638,278 83,928
2023-12-31 $4,367,333 86,328
2023-09-30 $3,940,740 86,877
2023-06-30 $3,603,131 87,817
2023-03-31 $2,881,251 80,617
2022-12-31 $3,044,904 80,617
2022-09-30 $3,753,490 84,863
2022-06-30 $3,084,432 83,318
2022-03-31 $3,106,285 83,863
2021-12-31 $213,010 7,000
2021-12-31 $2,576,295 84,663
2021-09-30 $4,102,042 122,303
2021-06-30 $4,665,654 116,963
2021-03-31 $5,608,220 124,738
2020-12-31 $6,905,682 122,138
2020-09-30 $5,814,428 122,538
2020-06-30 $7,462,920 126,576
2020-03-31 $6,469,133 136,826